{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:39Z","timestamp":1790633379863,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>While effective preventive measures reduce hospital-acquired infections (HAIs) and the spread of multi-drug resistant organisms (MDROs), studies on the impact of the COVID-19 pandemic and its associated preventive measures remain inconclusive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To assess the impact of COVID-19 on HAIs and MDROs and to compare it with the effect of seasonal influenza.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study analyzed prospectively collected data from a tertiary hospital in Haifa, northern Israel, from 2016 to 2021. It compared pre\/during COVID-19 and influenza (Dec-Feb)\/non-influenza (Mar-Nov) seasons. Studied parameters: hospital-acquired bloodstream infections (HA-BSI), MDROs, nosocomial <jats:italic>Clostridioides difficile<\/jats:italic> infections (CDI) per 10,000 hospital days (HD), central line-associated BSI (CLABSI) per 1000 catheter days (CD) and hand hygiene compliance (HHC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the COVID-19 period, rates of HAIs and MDROs decreased compared to the pre-COVID era for methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA) (4.2 vs. 6.9\/10,000 HD; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), carbapenem-resistant <jats:italic>Acinetobacter baumani<\/jats:italic> (CRAB) (2.2 vs. 3.1\/10,000 HD; <jats:italic>p<\/jats:italic>\u2009=\u20090.02), and nosocomial CDI (3 vs. 4.6\/10,000 HD; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). However, there was a higher rate of carbapenem-resistant Enterobacteriaceae (CRE) (4.6 vs. 2.7\/10,000 HD; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and HA-BSI (29.7 vs. 27.3\/10,000 HD; <jats:italic>p<\/jats:italic>\u2009=\u20090.006) during the COVID-19 era. CLABSI rates showed no significant difference (2.3 vs. 2.7\/1000 CD; <jats:italic>p<\/jats:italic>\u2009=\u20090.910). HHC rate remained at 70% in both eras (<jats:italic>p<\/jats:italic>\u2009=\u20090.151). No significant differences were observed in MDROs, CDI, HA-BSI, or CLABSI rates (<jats:italic>p<\/jats:italic>\u2009=\u20090.233, 0.675, 0.267, and 0.563, respectively) between influenza and non-influenza seasons.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In the COVID-19 era, HAIs and MDROs rates significantly declined, while CRE rates increased, possibly due to a national trend in Israel since 2016. Steady HHC rates suggest additional factors like enhanced environmental cleaning, personal protective equipment usage, and increased infection prevention awareness contributed to this decline. Influenza had no noticeable impact, likely due to healthcare workers\u2019 varying perceptions and the brevity of the influenza season, making it challenging to assess impact.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09240-0","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T12:53:14Z","timestamp":1732798394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of the COVID-19 pandemic on hospital-acquired infections and multi-drug resistant organisms, in comparison to seasonal influenza"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-3195","authenticated-orcid":false,"given":"Halima","family":"Dabaja-Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zmira","family":"Silman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Tarabeia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khetam","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"9240_CR1","doi-asserted-by":"crossref","unstructured":"De Georgeo MR, De Georgeo JM, Egan TM, Klee KP, Schwemm MS, ByeKollbaum H, et al. Containing SARS-CoV-2 in hospitals facing finite PPE, limited testing, and physical space variability: navigating resource constrained enhanced traffic control bundling. J Microbiol Immunol Infect. 2021;54:4\u201311.","DOI":"10.1016\/j.jmii.2020.07.009"},{"key":"9240_CR2","doi-asserted-by":"crossref","unstructured":"Li Z, Chen Q, Feng L, Rodewald L, Xia Y, Yu H, et al. China CDC COVID-19 Emergency Response Strategy Team. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet. 2020;396(10243):63\u201370.","DOI":"10.1016\/S0140-6736(20)31278-2"},{"key":"9240_CR3","doi-asserted-by":"crossref","unstructured":"Bentivegna E, Luciani M, Arcari L, Santino I, Simmaco M, Martelletti P. Reduction of Multidrug-Resistant (MDR) bacterial infections during the COVID-19 pandemic: a retrospective study. Int J Environ Res Public Health. 2021;18(3):1003.","DOI":"10.3390\/ijerph18031003"},{"key":"9240_CR4","doi-asserted-by":"crossref","unstructured":"Cole J, Barnard E. The impact of the COVID-19 pandemic on healthcare acquired infections with multidrug resistant organisms. Am J Infect Control. 2021;49(5):653\u20134.","DOI":"10.1016\/j.ajic.2020.09.013"},{"key":"9240_CR5","doi-asserted-by":"crossref","unstructured":"Gaspari R, Spinazzola G, Teofili L, Avolio AW, Fiori B, Maresca GM, Spanu T, Nicolotti N, De Pascale G, Antonelli M. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections. Eur J Clin Invest. 2021;51(12):e13687.","DOI":"10.1111\/eci.13687"},{"key":"9240_CR6","doi-asserted-by":"crossref","unstructured":"Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N, et al. CDC Prevention Epicenters Program. The impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated infections. Clin Infect Dis. 2022;74(10):1748\u201354.","DOI":"10.1093\/cid\/ciab688"},{"key":"9240_CR7","doi-asserted-by":"crossref","unstructured":"Jeon K, Jeong S, Lee N, Park MJ, Song W, Kim HS, et al. Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in bacterial infections. Antibiot (Basel). 2022;11(4):535.","DOI":"10.3390\/antibiotics11040535"},{"key":"9240_CR8","doi-asserted-by":"crossref","unstructured":"Perez S, Innes GK, Walters MS, Mehr J, Arias J, Greeley R, et al. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii infection and colonization in an Acute Care Hospital during a Surge in COVID-19 admissions - New Jersey, February-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(48):1827\u201331.","DOI":"10.15585\/mmwr.mm6948e1"},{"key":"9240_CR9","doi-asserted-by":"crossref","unstructured":"Zhou T, Guan R, Rosenthal SL, Moerdler S, Guan Z, Sun L. Supporting Health-Care workers and patients in Quarantine wards: evidence from a survey of Frontline Health-Care workers and inpatients with COVID-19 in Wuhan, China. Front Public Health. 2021;9:705354.","DOI":"10.3389\/fpubh.2021.705354"},{"key":"9240_CR10","doi-asserted-by":"crossref","unstructured":"Young KP, Kolcz DL, O\u2019Sullivan DM, Ferrand J, Fried J, Robinson K. Health Care Workers\u2019 Mental Health and Quality of Life during COVID-19: results from a mid-pandemic, National Survey. Psychiatr Serv. 2021;72(2):122\u20138.","DOI":"10.1176\/appi.ps.202000424"},{"key":"9240_CR11","doi-asserted-by":"crossref","unstructured":"Alsulimani LK, Farhat AM, Borah RA, AlKhalifah JA, Alyaseen SM, Alghamdi SM, et al. Health care worker burnout during the COVID-19 pandemic: a cross-sectional survey study in Saudi Arabia. Saudi Med J. 2021;42(3):306\u201314.","DOI":"10.15537\/smj.2021.42.3.20200812"},{"key":"9240_CR12","doi-asserted-by":"crossref","unstructured":"Evanoff BA, Strickland JR, Dale AM, Hayibor L, Page E, Duncan JG, et al. Work-related and personal factors Associated with Mental Well-being during the COVID-19 response: survey of Health Care and other workers. J Med Internet Res. 2020;22(8):e21366.","DOI":"10.2196\/21366"},{"key":"9240_CR13","unstructured":"Hand hygiene technical. reference manual: to be used by health-care workers, trainers and observers of hand hygiene practices https:\/\/www.who.int\/teams\/integrated-health-services\/infection-prevention-control\/hand-hygiene\/monitoring-tools."},{"key":"9240_CR14","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Approved standard M100-S19 2009, Clinical and Laboratory Standards Institute: Wayne, PA."},{"key":"9240_CR15","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Approved standard M100-S20 2010, Clinical and Laboratory Standards Institute: Wayne, PA."},{"key":"9240_CR16","doi-asserted-by":"crossref","unstructured":"Pasquini Z, Barocci I, Brescini L, Candelaresi B, Castelletti S, Iencinella V, et al. Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study. Int J Infect Dis. 2021;111:31\u20136.","DOI":"10.1016\/j.ijid.2021.07.065"},{"key":"9240_CR17","doi-asserted-by":"crossref","unstructured":"Palmore TN, Henderson DK. Healthcare-associated infections during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021;42(11):1372\u20133.","DOI":"10.1017\/ice.2021.377"},{"key":"9240_CR18","unstructured":"\u00d6nal U, T\u00fczemen \u00dc, Kazak E, Gen\u00e7ol N, Souleiman E, \u0130mer H, et al. Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units. Infez Med. 2023;31(2):195\u2013203."},{"key":"9240_CR19","doi-asserted-by":"crossref","unstructured":"Baloh J, Thom KA, Perencevich E, Rock C, Robinson G, Ward M, Herwaldt L, Reisinger HS. Hand hygiene before donning nonsterile gloves: Healthcareworkers\u2019 beliefs and practices. Am J Infect Control. 2019;47(5):492\u20137.","DOI":"10.1016\/j.ajic.2018.11.015"},{"key":"9240_CR20","doi-asserted-by":"crossref","unstructured":"Israel S, Harpaz K, Radvogin E, Schwartz C, Gross I, Mazeh H, et al. Dramatically improved hand hygiene performance rates at time of coronavirus pandemic. Clin Microbiol Infect. 2020;26(11):1566\u20138.","DOI":"10.1016\/j.cmi.2020.06.002"},{"key":"9240_CR21","doi-asserted-by":"crossref","unstructured":"Stangerup M, Hansen MB, Hansen R, Sode LP, Hesselbo B, Kostadinov K, et al. Hand hygiene compliance of healthcare workers before and during the COVID-19 pandemic: a long-term follow-up study. Am J Infect Control. 2021;49(9):1118\u201322.","DOI":"10.1016\/j.ajic.2021.06.014"},{"key":"9240_CR22","doi-asserted-by":"crossref","unstructured":"Moore LD, Robbins G, Quinn J, Arbogast JW. The impact of COVID-19 pandemic on hand hygiene performance in hospitals. Am J Infect Control. 2021;49(1):30\u20133.","DOI":"10.1016\/j.ajic.2020.08.021"},{"key":"9240_CR23","doi-asserted-by":"crossref","unstructured":"Ragusa R, Marranzano M, Lombardo A, Quattrocchi R, Bellia MA, Lupo L. Has the COVID 19 Virus Changed Adherence to hand washing among Healthcare Workers? Behav Sci (Basel). 2021;11(4):53.","DOI":"10.3390\/bs11040053"},{"key":"9240_CR24","doi-asserted-by":"crossref","unstructured":"Andrianopoulos I, Maniatopoulou T, Lagos N, Kazakos N, Papathanasiou A, Papathanakos G, et al. Acinetobacter baumannii Bloodstream infections in the COVID-19 era: a comparative analysis between COVID-19 and Non-COVID-19 critically ill patients. Microorganisms. 2023;11(7):1811.","DOI":"10.3390\/microorganisms11071811"},{"key":"9240_CR25","doi-asserted-by":"crossref","unstructured":"Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti M, et al. Hospital-Acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454\u201365.","DOI":"10.1016\/j.chest.2021.04.002"},{"key":"9240_CR26","unstructured":"The Israeli National Center for Infection Control. 2019 Annual Report on Bacterial Alert in General Hospitals. https:\/\/www.health.gov.il\/UnitsOffice\/HD\/InfectionControl\/Documents\/IC_Bacterial_alert_2019."},{"key":"9240_CR27","doi-asserted-by":"publisher","unstructured":"Meir-Gruber L, Manor Y, Gefen-Halevi S, Hindiyeh MY, Mileguir F, Azar R, Smollan G, Belausov N, Rahav G, Shamiss A, Mendelson E, Keller N. Population Screening Using Sewage Reveals Pan-Resistant Bacteria in Hospital and Community Samples. PLoS One. 2016;11(10):e0164873. https:\/\/doi.org\/10.1371\/journal.pone.0164873. Erratum in: PLoS One. 2017;12 (1):e0170538. PMID: 27780222; PMCID: PMC5079554.","DOI":"10.1371\/journal.pone.0164873"},{"key":"9240_CR28","doi-asserted-by":"crossref","unstructured":"Hussein K, Geffen Y, Eluk O, Warman S, Aboalheja W, Alon T, et al. The changing epidemiology of carbapenemase-producing enterobacterales. Rambam Maimonides Med J. 2022;13(1):e0004.","DOI":"10.5041\/RMMJ.10461"},{"key":"9240_CR29","doi-asserted-by":"crossref","unstructured":"Bentivegna E, Alessio G, Spuntarelli V, Luciani M, Santino I, Simmaco M, et al. Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection. Am J Infect Control. 2021;49(5):640\u20132.","DOI":"10.1016\/j.ajic.2020.09.010"},{"key":"9240_CR30","doi-asserted-by":"publisher","unstructured":"Ponce-Alonso M, S\u00e1ez de la Fuente J, Rinc\u00f3n-Carlavilla A, Moreno-Nunez P, Mart\u00ednez-Garc\u00eda L, Escudero-S\u00e1nchez R et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2021;42(4):406\u2013410. https:\/\/doi.org\/10.1017\/ice.2020.454. Epub 2020 Sep 8. Erratum in: Infect Control Hosp Epidemiol. 2021;42(2):250.","DOI":"10.1017\/ice.2020.454"},{"key":"9240_CR31","doi-asserted-by":"crossref","unstructured":"Ayenigbara IO, Adeleke OR, Ayenigbara GO, Adegboro JS, Olofintuyi OO. COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures. Germs. 2020;10(4):218\u201328.","DOI":"10.18683\/germs.2020.1208"},{"key":"9240_CR32","doi-asserted-by":"crossref","unstructured":"Houghton C, Meskell P, Delaney H, Smalle M, Glenton C, Booth A, et al. Barriers and facilitators to healthcare workers\u2019 adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;4(4):CD013582.","DOI":"10.1002\/14651858.CD013582"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09240-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09240-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09240-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T13:03:32Z","timestamp":1732799012000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09240-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9240"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09240-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"12 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Rambam Healthcare Campus Review Board (0201-20-RMB), informed consent was not required for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflict of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1364"}}